Signaling pathways
-
BA5456 BMS-986020Summary: BMS-986020 (AM152) is a high affinity lysophosphatidic acid receptor 1 antagonist. - BA5457 SLF1081851Summary: SLF1081851 is an inhibitor that suppresses release (=1.93 μM).
- BA5458 EtrasimodSummary: Etrasimod (APD334) is a highly potent selective and orally active receptor antagonist.
- BA5459 CAY10444Summary: CAY10444 (BML-241) is an antagonist.
- BA5460 CYM50358Summary: CYM50358 is a potent and selective antagonist.
- BA5461 AS2717638Summary: AS2717638 is an orally bioactive, selective antagonist.
- BA5462 GSK2018682Summary: GSK2018682 is an agonist.
- BA5463 GLPG2938Summary: GLPG2938 is a potent and selective antagonist.
- BA5464 CRT0273750Summary: CRT0273750 is a lead compound for ATX inhibitors and modulates plasma LPA levels.
- BA5465 CenerimodSummary: Cenerimod (ACT-334441) is a potent, selective and orally active receptor modulator.